These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19385120)

  • 1. [Efficacy of dynamic magnetic therapy in the complex treatment of cognitive disturbances in patients with chronic cerebrovascular insufficiency].
    Orekhova EM; Svistunov AA; Konchugova TV; Prikazchikova OA; Raĭgorodskiĭ IuM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):59-62. PubMed ID: 19385120
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
    Odinak MM; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular cognitive impairment.
    Bowler JV
    Stroke; 2004 Feb; 35(2):386-8. PubMed ID: 14757888
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of antihypertensive therapy in subclinical brain damage].
    Soucek M; Rihácek I; Frána P; Plachý M
    Vnitr Lek; 2011 Sep; 57(9):751-4. PubMed ID: 21957769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic disorders of cerebral blood circulation: possibilities of the use of cavinton].
    Kamchatnov PR; Zaĭtsev KA; Chugunov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(4 Suppl 2):52-6. PubMed ID: 20740716
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of lucetam for improvement of cognitive functions in chronic cerebrovascular insufficiency (clinical and encephalographic study)].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):44-8. PubMed ID: 18379503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P; Periti G; Colombo Pirola L
    Clin Ter; 1981 Apr; 97(2):137-45. PubMed ID: 7016415
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction.
    Balestreri R; Fontana L; Astengo F
    J Am Geriatr Soc; 1987 May; 35(5):425-30. PubMed ID: 3553281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of the combined drug vinpotropil at early stages of cerebrovascular insufficiency].
    Zakharov VV; Lokshina AB; Stakhovskaia LV; Timerbaeva SL; Lagoda OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):76-8. PubMed ID: 18686371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E; D'Alise R; Mea A; Vitagliano A
    Minerva Cardioangiol; 1975 Jan; 23(1):20-32. PubMed ID: 1143645
    [No Abstract]   [Full Text] [Related]  

  • 12. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
    Horváth S
    Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of vinpotropile in the therapy of initial signs of cerebrovascular pathology].
    Vorob'eva OV; Tamarova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):39-42. PubMed ID: 21183904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive functions and treatment of their impairment in elderly patients with the vertebrobasilar issufficiensy].
    Skoromets AA; Aliev KT; Lalayan TV; Pugachova EL; Smolko DG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(4):18-24. PubMed ID: 23739435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E; Di Lorenzo L; De Pergola G
    G Clin Med; 1980 Aug; 61(8):628-42. PubMed ID: 7004986
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cognitive disturbances and dysfunction of neuromediator systems in cerebral vascular insufficiency after treatment with pronoran].
    Bugrova SG; Novikov AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):63-5. PubMed ID: 18689025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
    Murashko NK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):51-5. PubMed ID: 18427520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G; Nappi G; Bono G
    Minerva Med; 1974 May; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vascular cognitive impairment in young patients].
    Dolgova IN; Starodubtsev AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):14-6. PubMed ID: 21510448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.